Skip to content
Telehealth Graded

Search Telehealth Graded

Use arrow keys or Tab to browse. Enter opens a result. Escape closes search.

Enter a name or topic to search.

State guide

North Carolina Medicaid and GLP-1s

For about ten weeks in late 2025, North Carolina Medicaid stopped paying for Wegovy and Zepbound for weight management. Then it started again. Both moves are documented in the state's own bulletins, and the coverage that came back isn't quite the coverage that left.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

2
documents cited
6
sourced facts
2
primary sources

What changed, and what the document says

  1. Coverage ended

    Not covered

    Discontinued on October 1, 2025.

    “Effective Oct. 1, 2025, NC Medicaid coverage for GLP-1s for the treatment of obesity will be discontinued.”

    NC Medicaid, Division of Health Benefits — September 5, 2025

  2. Why

    Context

    Money, stated plainly — and the same federal point Pennsylvania made: this is a benefit a state chooses.

    “Given shortfalls in state funding, effective Oct. 1, 2025, NC Medicaid coverage for GLP-1s for the treatment of obesity, which is an optional benefit for Medicaid programs, will be discontinued.”

    NC Medicaid, Division of Health Benefits — September 5, 2025

  3. What stayed covered through the gap

    Covered

    Four other indications, none of which is weight loss on its own.

    “GLP-1s will continue to be covered for the indications of diabetes, reduction in cardiovascular death, heart attack and stroke in obese adults with cardiovascular disease, noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and severe obstructive sleep apnea (OSA).”

    NC Medicaid, Division of Health Benefits — September 5, 2025

  4. Coverage came back

    Covered

    Reinstated effective December 12, 2025 — a week before the bulletin announcing it.

    “Effective Dec. 12, 2025, coverage for GLP-1s for the treatment of obesity will be reverted to the coverage available as of Sept. 30, 2025.”

    NC Medicaid, Division of Health Benefits — December 19, 2025

  5. Who decided

    Context

    The governor, by directive — not a quiet formulary update.

    “In accordance with the Governor's directive, NC Medicaid coverage for GLP-1s for the treatment of obesity is being reinstated effective Dec. 12, 2025.”

    NC Medicaid, Division of Health Benefits — December 19, 2025

  6. The catch on the way back

    Conditions apply

    Wegovy is the one you get first. Zepbound and Saxenda sit behind it.

    “Wegovy is a Preferred Product. Zepbound and Saxenda are Non-Preferred Products.”

    NC Medicaid, Division of Health Benefits — December 19, 2025

Telehealth in North Carolina

Some providers pay us a commission when you sign up through our links, at no extra cost to you.

Which of these companies serve North Carolina?

Of the 284 companies we grade, 28 publish a list of the states they are licensed in. We checked 250 more and found no such list on any page we read; 6 we have not checked either way.

20 of those lists name North Carolina: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon, Peak Wellness, Sprout Health, Allara Health, and MEDvidi. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.